On Sept. 22, Raybould, Professor of Practice at the McGill Institute for the Study of Canada, will deliver a lecture at the McGill Faculty Club titled “Implementing the United Nations Declaration on the Rights of Indigenous Peoples: Opportunities and Challenges.”
Earlier today, Ferring Pharmaceuticals announced a $2 million donation to McGill. The Reporter spoke with Michel L. Pettigrew, BCom’76, President of the Executive Board and Chief Operating Officer of Ferring about the importance of this gift.
In advance of her March 16 lecture, Lily Cho spoke to the Reporter about everything from the Chinese diaspora and the negative impact of the Chinese Head Tax, to the unifying influence of Chinese restaurants.
In advance of her lecture as part of the upcoming conference, Canada on the Global Stage, Melissa Aronczyk, author and Rutgers communications professor discusses the importance of national identity for countries and their citizens with the Reporter.
Will Straw will bid farewell to his post as Director for the McGill Institute for the Study of Canada in August after five years at the helm. In an interview with the Reporter, Straw looks back at MISC’s last five years and ahead to what the future holds for him.
Prime Minister Justin Trudeau and his new Liberal government have enjoyed a significant honeymoon with Canadian voters in their first 100 days since winning last October’s general election. But, as McGill’s Political Science Professor Antonia Maioni observes in Four Burning Questions, now the hard part begins.
Nov. 19 marks the 50th anniversary of the publication of the single most important scientific article in the field of pain, “Pain Mechanisms: A New Theory” co-authored by McGill’s Ronald Melzack and the late Patrick Wall. Dr. Jeffrey Mogil discusses the significance of this groundbreaking paper.
In advance of his 2015 Eakin Lecture, the Reporter spoke to Dr. Craig Moyes, Visiting Eakin Fellow.
In advance of his public lecture Advances in Lung Cancer Diagnosis and Workup on Nov. 4, Dr. Jason Agulnik , medical director of the pulmonary oncology program at the Jewish General Hospital, discusses whether or not only smokers develop lung cancer; if there are tests to screen for the disease; and new advances in the treatment.
In advance of his appearance at the upcoming Trottier Symposium (Sept. 28-29), GMO expert Kevin Folta spoke to the Reporter about genetically modified foods.